Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial

André, Thierry; Boni, C.; Navarro, Matilde; Tabernero, Josep; Hickish, Tamas; Topham, C.; Bonetti, Andrea; R. Clingan, Philip; Bridgewater, John; Rivera, Fernando; de Gramont, Aimery

doi:10.1200/jco.2008.20.6771

Public

Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial

Published in Journal of Clinical Oncology • May 19, 2009

Authors:

Thierry André

C. Boni

Matilde Navarro

Abstract

PURPOSE Three-year disease-free survival (DFS) was significantly improved in patients who had undergone resection with curative intent for stage II or III colon cancer who received bolus plus continuous-infusion fluorouracil plus leucovorin (LV5FU2) with the addition of oxaliplatin (FOLFOX4). Final ...

Subject

Medicine

Oxaliplatin

Fluorouracil

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!